Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.10 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: a27.15, e2.3, pabinafusp alfa | 0.72 |
| trials ClinicalTrials.gov | 2 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 11 Parkinson's papers of 1,071 | 0.67 |
| pathways Reactome | 18 pathways; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 2699
Sealed predictions
- TFRC in dopamine neurons, braak+0.37 (p 0.321) → +0.12 (p 0.750)receipt 2706
Swarm cases
receipt 2706: TFRC in dopamine neurons, braak
- power
- full sample +0.14 (p 0.585, n 18), 95% CI -0.35 to +0.57. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.854, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.05 (p 0.854, n 18). could be the mix.
- skeptic
- leave-one-out range +0.06 to +0.26, sign flips 0; without severely affected donors +0.14 (p 0.585, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TFRC in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts